Ng George K Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
2
Insider Buys Sum
$96,542.00
Insider Sells Quantity
0
Insider Sells Sum
$0

Insider Activity of Ng George K

According to the SEC Form 4 filings, Ng George K, being in a position of

  1. Chief Executive Officer at Processa Pharmaceuticals, Inc.,
    оver the last 12 months, has bought 15507 shares for $38,677, and sold 0 shares,
    over all time since 2024-01-30, has bought 112707 shares for $135,219, and sold 0 shares.

Biography of Ng George K

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
 $38,6777100
Sells
 $000

Comparison of Insiders on Amount of Buys and Sells

2026-07-01PurchaseProcessa Pharmaceuticals, Inc.
PCSA
Chief Executive Officer
3,057
0.1356%
$1.93$5,900+4.08%
2026-06-15PurchaseProcessa Pharmaceuticals, Inc.
PCSA
Chief Executive Officer
2,465
0.1093%
$2.22$5,472-8.37%
2026-05-29PurchaseProcessa Pharmaceuticals, Inc.
PCSA
Chief Executive Officer
2,129
0.0943%
$2.57$5,472-19.92%
2026-05-15PurchaseProcessa Pharmaceuticals, Inc.
PCSA
Chief Executive Officer
1,843
0.0816%
$2.97$5,474-30.07%
2026-04-30PurchaseProcessa Pharmaceuticals, Inc.
PCSA
Chief Executive Officer
2,034
0.0911%
$2.69$5,471-22.22%
2026-04-15PurchaseProcessa Pharmaceuticals, Inc.
PCSA
Chief Executive Officer
1,843
0.0816%
$2.97$5,474-28.04%
2026-03-31PurchaseProcessa Pharmaceuticals, Inc.
PCSA
Chief Executive Officer
2,136
0.0946%
$2.54$5,415-15.02%
2025-01-27PurchaseProcessa Pharmaceuticals, Inc.
PCSA
Chief Executive Officer
87,200
3.0679%
$0.80$69,542-58.6%
2024-01-30PurchaseProcessa Pharmaceuticals, Inc.
PCSA
Chief Executive Officer
10,000
0.4872%
$2.70$27,000-41.48%
Total: 9
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsInsider RatioList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.